7QIQ image
Deposition Date 2021-12-15
Release Date 2022-03-09
Last Version Date 2024-01-31
Entry Detail
PDB ID:
7QIQ
Keywords:
Title:
CRYSTAL STRUCTURE OF THE P1 aminobutanoic acid (ABU) BPTI MUTANT- BOVINE CHYMOTRYPSIN COMPLEX
Biological Source:
Source Organism:
Bos taurus (Taxon ID: 9913)
Method Details:
Experimental Method:
Resolution:
1.85 Å
R-Value Free:
0.18
R-Value Work:
0.16
R-Value Observed:
0.16
Space Group:
P 61
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Chymotrypsin A chain A
Chain IDs:A, E
Chain Length:13
Number of Molecules:2
Biological Source:Bos taurus
Polymer Type:polypeptide(L)
Molecule:Chymotrypsin A chain B
Chain IDs:B, F
Chain Length:131
Number of Molecules:2
Biological Source:Bos taurus
Polymer Type:polypeptide(L)
Molecule:Chymotrypsin A chain C
Chain IDs:C, G
Chain Length:97
Number of Molecules:2
Biological Source:Bos taurus
Polymer Type:polypeptide(L)
Molecule:Pancreatic trypsin inhibitor
Chain IDs:D, H
Chain Length:58
Number of Molecules:2
Biological Source:Bos taurus
Primary Citation
Fluorine-induced polarity increases inhibitory activity of BPTI towards chymotrypsin.
Rsc Chem Biol 3 773 782 (2022)
PMID: 35755190 DOI: 10.1039/d2cb00018k

Abstact

Substituting the P1 position in bovine pancreatic trypsin inhibitor (BPTI) is known to heavily influence its inhibitory activity towards serine proteases. Side-chain fluorinated aliphatic amino acids have been shown to alter numerous properties of peptides and proteins and thus are of interest in the context of BPTI. In our study, we systematically investigated the site-specific incorporation of non-canonical amino acids into BPTI by microwave-assisted solid-phase peptide synthesis (SPPS). Inhibitor activity of the variants was tested towards the serine protease α-chymotrypsin. We observed enhanced inhibition of two fluorinated BPTIs compared to wild type and hydrocarbon variants. To further investigate the complexes, we performed X-ray structure analysis. Our findings underline the power fluorine offers as a tool in protein engineering to beneficially alter the effects on phenomena as protein-protein interactions.

Legend

Protein

Chemical

Disease

Primary Citation of related structures